English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduMount Sinai International (MSI), a part of the Mount Sinai Health System in New York that focuses on advancing health care across the world, will participate in the International Health Ministerial Summit in Kigali, Rwanda, on Wednesday and Thursday, December 4-5.
Tag: HIV/AIDS
For People Living with HIV/AIDS, TB is Still the Leading Cause of Death
The latest World Health Organization’s Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were newly diagnosed with TB in 2023, the highest number since the organization began global TB monitoring in 1995. TB is the leading cause of death among those with HIV /AIDS worldwide. According to the WHO, in 2023, 161,000 people died of HIV-associated TB.
2024 WORLD AIDS DAY: Collective Action Needed to End HIV/AIDS, Common Ground for Divided Nation
This World AIDS Day Sunday, December 1, the Center for Latino Adolescent and Family Health (CLAFH) along with the Institute for Policy Solutions (IPS) at Johns Hopkins School of Nursing is calling all sectors to act.
Mount Sinai Doctors to Present at ID Week 2024
Experts in infection prevention and control available for interview about research findings and other breaking health topics including the flu, COVID, HIV, mpox, West Nile, and vaccinations
SE NECESITAN URGENTEMENTE NUEVOS ENFOQUES PARA ERRADICAR LA CRISIS DEL VIH/SIDA EN LA POBLACIÓN LATINA
En un nuevo artículo de investigación publicado {hoy/esta semana} en la revista médica New England Journal of Medicine, los expertos en el tema recomiendan encarecidamente que todos los sectores de la comunidad de atención de la salud actualicen sus enfoques para poder enfrentar la crisis permanente del VIH/SIDA en la población latina. Este llamado a la acción surge en un momento en el que se refleja un progreso general en el esfuerzo realizado por varias décadas para erradicar la epidemia en los Estados Unidos.
URGENT NEW APPROACHES NEEDED TO END HIV/AIDS CRISIS AMONG LATINOS
In a new paper published on October 9 in the New England Journal of Medicine, experts are urging all sectors of the health care community to urgently evolve their approaches to meet the continuing HIV/AIDS crisis among Latinos. This call-to-action comes at a time when the decades-long effort to end the epidemic in the U.S. is showing overall
progress.
New Trial Highlights Incremental Progress Towards a Cure for HIV-1
A new clinical trial, led by clinicians and researchers at the UNC School of Medicine, show that the combination of the drug vorinostat and immunotherapy may modestly shrink the latent HIV reservoir, but more work needs to be done in the field to create a cure.
NIH grants support UCLA and Charles Drew University researchers’ efforts to end HIV epidemic
The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.
UTHealth Houston researchers analyze cancer discrepancies among young Black men in the South
Research shows that incidences of Kaposi’s sarcoma among people living with HIV have fallen significantly over the past two decades, but a new evaluation of data led by researchers at UTHealth Houston highlights a significant disparity among one particular demographic – young Black men in the American South.
Study shows HIV speeds up body’s aging processes soon after infection
HIV has an “early and substantial” impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection.
Albert Einstein College of Medicine Receives $11.3M NIH Grant to Expand the Einstein-Rockefeller-CUNY Center for AIDS Research
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR) and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally, and internationally.
Case Western Reserve University receives $16M federal grant to launch major research center on substance use and HIV
Thanks to a new $16 million, five-year grant from the National Institute on Drug Abuse of the National Institutes of Health, Case Western Reserve University is launching a multi-institutional research effort dedicated to deepening understanding of the relationship between substance use and HIV.
Virtual Village Treats HIV-associated Loneliness in Novel UC San Diego Health Trial
A new trial by UC San Diego Health infectious disease specialist Maile Young Karris, MD, will use longitudinal questionnaires and qualitative interviews to assess the impact of living in an interconnected virtual village on the loneliness known to afflict older people with HIV.
Researchers receive $122m to study monthly HIV pill
Global health researchers at the University of Washington have received a $122 million grant from the Bill & Melinda Gates Foundation to test the effectiveness of a once-a-month oral pill to prevent HIV.
ACTG TO PRESENT 24 NEW STUDIES AT CROI 2021
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, will present four oral and 20 scientific spotlight sessions at the Conference on Retroviruses and Opportunistic Infections (CROI 2021) held virtually, March 6-10.
Rutgers Expert Available to Comment on Higher COVID-19 Rates Among Nonwhite LGBTQ Population
Lesbian, gay, bisexual, transgender and queer (LGBTQ) people of color are disproportionately experiencing the impact of COVID-19. “We can’t treat the LGBTQ community as a monolith and must attend to the diversity within this population,” says Perry N. Halkitis, dean…
Research News Tip Sheet: Story Ideas From Johns Hopkins Medicine
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.
UC San Diego Selected to Lead International HIV/AIDS Clinical Trials Unit
University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials.
Johns Hopkins Bloomberg School of Public Health Appoints David Celentano as New Bloomberg Centennial Professor
Johns Hopkins Bloomberg School of Public Health has appointed David Celentano, ScD, MHS, as a Bloomberg Centennial Professor.
ACTG STUDIES AT AIDS 2020: VIRTUAL
Topics include the efficacy and safety of third-line treatment regimens in resource-limited settings, viral rebound rates after treatment interruption of modern ART, and whether a standardized frailty score can improve clinicians’ ability to estimate cardiovascular risk among older people with HIV.